Switch to:
More From Other Websites
Incyte Has Bad Data and Worse Timing Feb 11 2016
Relypsa: This Biotech Just Released Stunning Data Feb 10 2016
Abbvie expects to bring endometriosis drug to FDA in 2017 Feb 10 2016
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
Short Sellers Increase Bets in Major Pharma Feb 10 2016
5 Safe, Strong Stocks to Add to Your Portfolio in Uncertain Times Feb 10 2016
AbbVie, Maker of World's No. 1 Drug, Bets on Synthetic Biology Startup Feb 10 2016
6:56 am AbbVie, in cooperation with Neurocrine Biosciences (Feb 10 2016
AbbVie Announces Positive Top-Line Results From Second Phase 3 Study Investigating Elagolix in... Feb 10 2016
Panel Recommends FDA Approval of Remicade Knockoff Feb 10 2016
20 dividend stocks that Wall Street loves the most Feb 09 2016
The market in a minute: 5 stocks I really like Feb 08 2016
4 Big Dividend Pharmaceutical Stocks to Buy That Are Very Cheap Now Feb 08 2016
[$$] J&J, AbbVie Shares Drop on Potential Drug Competition Feb 05 2016
[$$] J&J, AbbVie Shares Drop on Potential Drug Competition Feb 05 2016
It’s Time to Buy This Biotech Gem Feb 04 2016




Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK